Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-05-15
2007-05-15
Li, Ruixiang (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
10747702
ABSTRACT:
The present invention is directed to novel G protein-coupled receptors that are found predominantly in the dorsal root ganglia. The invention encompasses both the receptor proteins as well as nucleic acids encoding the proteins. In addition, the present invention is directed to methods and compositions which utilize the receptors.
REFERENCES:
patent: WO 94/05695 (1994-03-01), None
patent: WO 95/04073 (1995-02-01), None
Bowie, et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science 247:1306-1310 (1990).
Brown, et al., “Gastrointestinal Adaptation to Enhanced Small Intestinal Lipid Exposure,”Gut 35:1409-1412 (1994).
Caron, et al., “Catecholamine Receptors: Structure, Function, and Regulation,”Rec. Prog. Horm. Res. 48:277-290 (1993).
Freedman, et al., “Desensitization of G Protein-Coupled Receptors,”Rec. Prog. Horm. Res. 51:319-353 (1996).
Gudermann, et al., “Receptors and G Proteins as Primary Components of Transmembrane Signal Transduction,”J. Mol. Med. 73:51-63 (1995).
Mikayama, “Molecular Cloning and Functional Expression of cDNA Encoding Glycosylation-Inhibiting Factor,”Proc. Natl. Acad. Sci. USA 90:10056-10060 (1993).
Oldfield, et al., “Distribution of Angiotensin II Receptor Binding in the Spinal Cord of the Sheep,”Brain Res. 650:40-48 (1994)—Dialog abstr., file 154, MEDLINE, Dialog acc. No. 09044093, Medline acc. No. 95041487.
Shapiro, et al., “Angiotensin-II Inhibits Calcium and M-Current Channels in Rat Sympathetic Neurons via G-Proteins,”Neuron 12:1319-1329 (1994)—Dialog abstr., file 34, SciSearch, Dialog acc. No. 03259572.
Stromberg, et al., Angiotensin II ATI Receptors in Rat Superior Cervical Ganglia Characterization and Stimulation of Phosphoinositide Hydrolysis,Eur. J. Pharmacol. 208:331-336 (1991)—Dialog abstr., file 154, MEDLINE, Dialog acc. No. 0692770, Medline acc No. 92275043.
Voet, et al.,Biochemistry, John Wiley & Sons, Inc., pp. 126-128 and 228-234 (1990).
Handy et al., “Shotgun (sequencing) wedding: can human gene patents and science live happily ever after?” Biotechnology Law Report (2000) 19(6):801-813.
Larhammer et al., “The receptor revolution-multiplicity of G-protein-coupled receptors,” Drug Design and Discovery (1993) 9:179-188.
Lembo et al., “Proenkephalin A gene products activate a new family of sensory neuron-specific GBCRs,” Nature Neuroscience (2002) 5(3):201-209.
Wilson et al., “Orphan G-protein-coupled receptors: the next generation of drug targets?” British J Pharmacol (1998) 125:1378-1392.
European Offical Communication dated May 8, 2003 for EP Application No. 98964614.6-2405.
Ahmad Sultan
Banville Denis
Fortin Yves
Lembo Paola
O'Donnell Dajan
Li Ruixiang
National Research Council of Canada
Pepper Hamilton LLP
Quartin Robin
LandOfFree
Human G protein-coupled receptor expressed in the dorsal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human G protein-coupled receptor expressed in the dorsal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human G protein-coupled receptor expressed in the dorsal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3724398